In prostate cancer, therapeutically targeting this stress response via inhibition of phosphorylated eukaryotic initiation factor 2 α (P-eIF2α) promoted a cytotoxic response in metastatic prostate PDXs [48]. The gene discussed is EIF2A; the disease is prostate cancer.